Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04532424 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
A NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT04532424: Recruiting NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.
NCT04532424 is a NA study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by Stanford University. The registered enrollment target is 67 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04532424, a NA study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigating the efficacy of a form of TMS called theta-burst stimulation for restricted and repetitive behavior in ASD.
Primary Outcome
44-item parent-report questionnaire to measure restricted and repetitive behavior in ASD. We predict that each TMS target will selectively reduce the subscale being targeted.
Conditions Studied
Interventions
- DEVICE Transcranial magnetic stimulation
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2029-12-01 |
| Phase | NA |
What NCT04532424 shows while recruiting
NCT04532424 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (50% lower).
The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial magnetic stimulation is the first listed.
NCT04532424 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04532424 about?
NCT04532424 is a clinical study titled "Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD". Investigating the efficacy of a form of TMS called theta-burst stimulation for restricted and repetitive behavior in ASD.
What is the current status of trial NCT04532424?
This trial is currently recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2021-01-04. Estimated completion is 2029-12-01.
What conditions does trial NCT04532424 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Asperger Syndrome.
What interventions are being tested in trial NCT04532424?
The interventions under investigation include: Transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT04532424?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04532424 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04532424's enrollment target sits among peer trials
67 113th of 224 higher than 112 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT05003986 · 67 participants · Phase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI